12/22/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – rabeprazolnatrium (vattenfri)

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Rabeprazol

Rabeprazol

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R. The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci. 2012;57(3):699-705.

  2. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363:2114-23.

  3. Diav-Citrin O, Arnon J, Shechtman S, Shaefer C, van Tonningen MR, Clementi M et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005;21:269-75.

  4. Choi A, Noh Y, Jeong HE, Choi EY, Man KKC, Han JY et al. Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations. JAMA Netw Open. 2023;6(1):e2250366.

  5. Källén BA. Use of omeprazole during pregnancy no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 2001;96:63-8.

  6. Ruigomez A, Garcia Rodriguez LA , Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999;150:476-81.

  7. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998;105:877-81.

  8. Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Mastroiacovo P, Mazzone T et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998;179:727-30.

  9. Erichsen R, Mikkelsen E, Pedersen L, Sørensen HT. Maternal use of proton pump inhibitors during early pregnancy and the prevalence of hypospadias in male offspring. Am J Ther. 2014;21(4):254-9.

  10. Choi A, Noh Y, Yon DK, Shin JY. Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019. JAMA Netw Open. 2023;6(4):e237962.

  11. Lai T, Wu M, Liu J, Luo M, He L, Wang X et al. Acid-Suppressive Drug Use During Pregnancy and the Risk of Childhood Asthma: A Meta-analysis. Pediatrics. 2018;141(2):e20170889

  12. Noh Y, Jeong HE, Choi A, Choi EY, Pasternak B, Nordeng H et al. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children. JAMA Pediatr. 2023;177(3):267-277.

  1. Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R. The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci. 2012;57(3):699-705.
  2. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363:2114-23.
  3. Diav-Citrin O, Arnon J, Shechtman S, Shaefer C, van Tonningen MR, Clementi M et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005;21:269-75.
  4. Choi A, Noh Y, Jeong HE, Choi EY, Man KKC, Han JY et al. Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations. JAMA Netw Open. 2023;6(1):e2250366.
  5. Källén BA. Use of omeprazole during pregnancy no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 2001;96:63-8.
  6. Ruigomez A, Garcia Rodriguez LA , Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999;150:476-81.
  7. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998;105:877-81.
  8. Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Mastroiacovo P, Mazzone T et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998;179:727-30.
  9. Erichsen R, Mikkelsen E, Pedersen L, Sørensen HT. Maternal use of proton pump inhibitors during early pregnancy and the prevalence of hypospadias in male offspring. Am J Ther. 2014;21(4):254-9.
  10. Choi A, Noh Y, Yon DK, Shin JY. Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019. JAMA Netw Open. 2023;6(4):e237962.
  11. Lai T, Wu M, Liu J, Luo M, He L, Wang X et al. Acid-Suppressive Drug Use During Pregnancy and the Risk of Childhood Asthma: A Meta-analysis. Pediatrics. 2018;141(2):e20170889
  12. Noh Y, Jeong HE, Choi A, Choi EY, Pasternak B, Nordeng H et al. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children. JAMA Pediatr. 2023;177(3):267-277.